Advertisement

Journal of Assisted Reproduction and Genetics

, Volume 28, Issue 3, pp 279–284 | Cite as

Pronuclear embryo cryopreservation experience: outcomes for reducing the risk of ovarian hyperstimulation syndrome and for fertility preservation in cancer patients

  • Mary E. Sabatini
  • Ann M. Wolkovich
  • Eric A. Macklin
  • Diane L. Wright
  • Irene Souter
  • Thomas L. Toth
Fertility Preservation

Abstract

Purpose

To evaluate pregnancy rate (PR) and live birth rate (LBR) after freezing pronuclear (PN) embryos for two purposes: to reduce the risk of ovarian hyperstimulation syndrome (OHSS) and to bank embryos for cancer patients anticipating gametotoxic chemotherapy/radiotherapy.

Methods

Data from 3,621 consecutive IVF cycles were retrospectively analyzed. PN freezing was offered to patients at risk for OHSS and for those wishing to preserve fertility prior to cancer therapy. Primary outcomes evaluated were PR and LBR. Outcomes were compared to patients who underwent fresh embryo transfer (ET) in 2006.

Results

Sixty-six patients froze PN embryos. Thirty-eight were at risk for OHSS. The LBR was 34.3% after one transfer, and 51.4% after a mean of 1.4 transfers. Twenty-eight cancer patients froze embryos. The LBR was 16.7% after one transfer and 25.0% after a mean of 1.5 transfers. The LBR was 35.5% for patients who underwent fresh ET.

Conclusion

PN freezing with delayed ET is an effective tool for achieving pregnancy for patients at risk of OHSS and for cancer patients wishing to preserve fertility.

Keywords

Ovarian hyperstimulation syndrome OHSS IVF Cancer Fertility preservation 

Notes

Acknowledgements or Funding Sources

None

References

  1. 1.
    Trounson A, Mohr L. Human pregnancy following cryopreservation, thawing and transfer of an eight cell embryo. Nature. 1983;305(5936):707–9.PubMedCrossRefGoogle Scholar
  2. 2.
    Zeilmaker GH, Alberda AT, Van Gent I, Rijkmans CMPM, Drogendijk AC. Two pregnancies following transfer of intact frozen-thawed embryos. Fertil Steril. 1984;42(2):293–6.PubMedGoogle Scholar
  3. 3.
    Mohr LR, Trounson A, Freeman L. Deep-freezing and transfer of human embryos. J IVF. 1985;2:1–10.Google Scholar
  4. 4.
    Downing BG, Mohr LR, Trounson AO, Freemann LE, Wood C. Birth after transfer of cryopreserved embryos. Med J Aust. 1985;142(7):409–11.PubMedGoogle Scholar
  5. 5.
    Veeck LL. Chapter 9 cryopreservation. In: An atlas of human gametes and conceptuses. New York: Parthenon; 1999. p. 69–75.Google Scholar
  6. 6.
    Rizk B, Aboulghar MA. Classification, pathophysiology, and management of ovarian hyperstimulation syndrome. In: Brinsden P, editor. In vitro fertilization and assisted reproduction. New York: Parthenon; 1999. p. 131–55.Google Scholar
  7. 7.
    Sher G, Zouves C, Feinman M, Maassarani G. ‘Prolonged coasting’: an effective method for preventing severe ovarian hyperstimulation syndrome in patients undergoing in-vitro fertilization. Hum Reprod. 1995;10(12):3107–9.PubMedGoogle Scholar
  8. 8.
    Mansour R, Aboulghar M, Serour G, Amin Y, Abou-Setta AM. Criteria of a successful coasting protocol for the prevention of severe ovarian hyperstimulation syndrome. Hum Reprod. 2005;20(11):3167–72.PubMedCrossRefGoogle Scholar
  9. 9.
    Nargund G, Hutchison L, Scaramuzzi R, Campbell S. Low-dose HCG is useful in preventing OHSS in high-risk women without adversely affecting the outcome of IVF cycles. Reprod Biomed Online. 2007;14(6):682–5.PubMedCrossRefGoogle Scholar
  10. 10.
    Griesinger G, Diedrich K, Devroey P, Kolibianakis EM. GnRH agonist for triggering final oocyte maturation in the GnRH antagonist ovarian hyperstimulation protocol: a systematic review and meta-analysis. Hum Reprod Update. 2006;12(2):159–68.PubMedCrossRefGoogle Scholar
  11. 11.
    Aboulghar M. Symposium: update on prediction and management of OHSS. Reprod Biomed Online. 2009;19(1):33–42.PubMedCrossRefGoogle Scholar
  12. 12.
    Shaker AG, Zosmer A, Dean N, Bekir JS, Jacobs HS, Tan SL. Comparison between intravenous albumin and transfer of fresh embryos with cryopreservation of all embryos for subsequent transfer in prevention of ovarian hyperstimulation syndrome. Fertil Steril. 1996;65:992–6.PubMedGoogle Scholar
  13. 13.
    Alvarez C, Alonso-Muriel I, Garcia G, Crespo J, Bellver J, Simon C, et al. Implantation is apparently unaffected by the dopamine agonist Cabergoline when administered to prevent ovarian hyperstimulation syndrome in women undergoing assisted reproduction treatment: a pilot study. Hum Reprod. 2007;22(12):3210–4.PubMedCrossRefGoogle Scholar
  14. 14.
    Busso CE, Garcia-Velasco J, Gomez R, Alvarez C, Simon C, Pellicer A. Symposium: update on prediction and management of OHSS. Prevention of OHSS-dopamine agonists. Reprod Biomed Online. 2009;19(1):43–51.PubMedCrossRefGoogle Scholar
  15. 15.
    Ferraretti AP, Giananroli L, Magli C, Fortini D, Selman HA, Feliciani E. Elective cryopreservation of all pronucleate embryos in women at risk of ovarian hyperstimulation syndrome: efficiency and safety. Hum Reprod. 1999;14(6):1457–60.PubMedCrossRefGoogle Scholar
  16. 16.
    Tiitinen A, Husa LM, Tulppala M, Simberg N, Seppala M. The effect of cryopreservation in prevention of ovarian hyperstimulation syndrome. Br J Obstet Gynaecol. 1995;102(4):326–9.PubMedCrossRefGoogle Scholar
  17. 17.
    Sills ES, McLoughlin LJ, Genton MG, Walsh DJ, Coull GD, Walsh APH. Ovarian hyperstimulation syndrome and prophylactic human embryo cryopreservation: Analysis of reproductive outcome following thawed embryo transfer. J Ovarian Res. 2008;1(1):7–13.PubMedCrossRefGoogle Scholar
  18. 18.
    Queenan JT, Veeck LL, Toner JP, Oehninger S, Muasher SJ. Cryopreservation of all prezygotes in patients at risk of severe hyperstimulation does not eliminate the syndrome, but the chances of pregnancy are excellent with subsequent frozen-thaw transfers. Hum Reprod. 1997;12(7):1573–6.PubMedCrossRefGoogle Scholar
  19. 19.
    Frederick JL, Ord T, Kettel LM, Stone SC, Balmaceda JP, Asch RH. Successful pregnancy outcome after cryopreservation of all fresh embryos with subsequent transfer into an unstimulated cycle. Fertil Steril. 1995;64(5):987–90.PubMedGoogle Scholar
  20. 20.
    Vyjayanthi S, Tang T, Fattah A, Deivanayagam M, Bardis N, Latrikes P, et al. Elective cryopreservation of embryos at the pronucleate stage in women at risk of ovarian hyperstimulation syndrome may affect the overall pregnancy rate. Fertil Steril. 2006;86(6):1773–5.PubMedCrossRefGoogle Scholar
  21. 21.
    Awonuga AO, Pittrof RJ, Zaidi J, Dean N, Jacobs HS, Tan SL. Elective cryopreservation of all embryos in women at risk of developing ovarian hyperstimulation syndrome may not prevent the condition but reduces the live birth rate. J Assist Reprod Genet. 1996;13(5):401–6.PubMedCrossRefGoogle Scholar
  22. 22.
    Pattinson HA, Hignett M, Dunphy BC, Fleetham JA. Outcome of thaw embryo transfer after cryopreservation of all embryos in patients at risk of ovarian hyperstimulation syndrome. Fertil Steril. 1994;62(6):1192–6.PubMedGoogle Scholar
  23. 23.
    Gera PS, Tatpati LL, Allemand MC, Wentworth MA, Coddington CC. Ovarian hyperstimulation syndrome: steps to maximize success and minimize effect for assisted reproductive outcome. Fertil Steril. 2010;94(1):173–8.PubMedCrossRefGoogle Scholar
  24. 24.
    Pal L, Leykin L, Shifren JL, Isaacson KB, Chan YC, Nikruil N, et al. Malignancy may adversely influence the quality and behaviour of oocytes. Hum Reprod. 1998;13:1937–40.CrossRefGoogle Scholar
  25. 25.
    Michaan N, Ben-David G, Ben-Yosef D, Almog B, Many A, Pauzner D, et al. Ovarian stimulation and emergency in vitro fertilization for fertilitypreservation in cancer patients. Eur J Obstet Gynecol Reprod Biol. 2010;149(2):175–7.PubMedCrossRefGoogle Scholar
  26. 26.
    Ginsburg ES, Yanushpolsky EH, Jackson KV. In vitro fertilization for cancer patients and survivors. Fertil Steril. 2001;75(4):705–10.PubMedCrossRefGoogle Scholar
  27. 27.
    Styer AK, Wright DL, Wolkovich AM, Viega C, Toth TL. Single blastocyst transfer decreases twin gestation without affecting pregnancy outcome. Fertil Steril. 2008;89(6):1702–8.PubMedCrossRefGoogle Scholar
  28. 28.
    Testart J, Lassalle B, Belaisch-Allart J, Hazout A, et al. High pregnancy rate after early human embryo freezing. Fertil Steril. 1986;46:268.PubMedGoogle Scholar
  29. 29.
    Veeck LL, Zaninovic N. Blastocyst cryopreservation and thawing. In: An atlas of human blastocysts. New York: Parthenon; 2003. p. 179.Google Scholar
  30. 30.
    American Society of Reproductive Medicine Guidelines on number of embryos transferred. Fertil Steril. 2006;86(4):S51–52.Google Scholar
  31. 31.
    Borini A, Cattoli M, Bulletti C, Coticchio G. Clinical efficiency of oocyte and embryo cryopreservation. Ann NY Acad Sci. 2008;1127:49–58.PubMedCrossRefGoogle Scholar
  32. 32.
    Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, et al. Cancer statistics, 2008. CA Cancer J Clin. 2008;58(2):71–96.PubMedCrossRefGoogle Scholar
  33. 33.
    Noyes N, Porcu E, Borini A. Over 900 oocyte cryopreservation babies born with no apparent increase in congenital anomalies. Reprod Biomed Online. 2009;18(6):69–776.CrossRefGoogle Scholar
  34. 34.
    Donnez J, Dolmans MM, Demylle D, Jadoul P, Pirard C, Squifflet J, et al. Livebirth after orthotopic transplantation of cryopreserved ovarian tissue. Lancet. 2004;364(9443):1405–10.PubMedCrossRefGoogle Scholar
  35. 35.
    Dolmans MM, Marinescu C, Saussoy P, Van Langendonckt A, Amorim C, Donnez J. Reimplantation of cryopreserved ovarian tissue from patients with acute lymphoblastic leukemia is potentially unsafe. Blood. 2010;116(16):2908–14.PubMedCrossRefGoogle Scholar
  36. 36.
    Jeruss JS, Woodruff TK. Preservation of fertility in patients with cancer. N Engl J Med. 2009;360(9):902–11.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • Mary E. Sabatini
    • 1
    • 2
  • Ann M. Wolkovich
    • 1
  • Eric A. Macklin
    • 2
    • 3
  • Diane L. Wright
    • 1
  • Irene Souter
    • 1
    • 2
  • Thomas L. Toth
    • 1
    • 2
  1. 1.Vincent Obstetrics and Gynecology ServiceMassachusetts General HospitalBostonUSA
  2. 2.Harvard Medical SchoolBostonUSA
  3. 3.Biostatistics CenterMassachusetts General HospitalBostonUSA

Personalised recommendations